Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
inflammatory5866 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A27000 | 19370776 | World J Gastroenterol | Olive oil consumption and non-alcoholic fatty liver disease. | 2009 | Details |
| A27005 | 19363256 | J Alzheimers Dis | Epidemilogical trends strongly suggest exposures as etiologic agents in the pathogenesis of sporadic Alzheimer's disease, diabetes mellitus, and non-alcoholic steatohepatitis. | 2009 | Details |
| A27011 | 19359149 | Nutr Metab Cardiovasc Dis | Hepatic lipid metabolism and non-alcoholic fatty liver disease. | 2009 | Details |
| A27012 | 19358839 | Eur J Pharmacol | Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats. | 2009 | Details |
| A27013 | 19355912 | Curr Mol Med | Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. | 2009 | Details |
| A27023 | 21495339 | Rev Med Chir Soc Med Nat Iasi | [Adipocytokines and nonalcoholic steatohepatitis]. | 2011 | Details |
| A27027 | 19321579 | J Nutr | Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. | 2009 | Details |
| A27038 | 19291292 | J Inflamm (Lond) | Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively? | 2009 | Details |
| A27041 | 19289381 | Gut | The effect of obesity on intrahepatic cytokine and chemokine expression in chronic hepatitis C infection. | 2009 | Details |
| A27046 | 19280268 | Obes Surg | Expression of cytokine signaling genes in morbidly obese patients with non-alcoholic steatohepatitis and hepatic fibrosis. | 2009 | Details |
| A27050 | 19268270 | Clin Gastroenterol Hepatol | Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease. | 2009 | Details |
| A27062 | 19240815 | Hippokratia | Non alcoholic fatty liver disease and metabolic syndrome. | 2009 | Details |
| A27074 | 19222113 | Am J Chin Med | Therapeutic effect of puerarin on non-alcoholic rat fatty liver by improving leptin signal transduction through JAK2/STAT3 pathways. | 2009 | Details |
| A27092 | 19195627 | Diabetes Metab | Adipose tissue inflammation and liver pathology in human obesity. | 2008 | Details |
| A27106 | 19165171 | Obesity (Silver Spring) | Liver NF-kappaB and AP-1 DNA binding in obese patients. | 2009 | Details |
| A27123 | 19135440 | Eur J Pharmacol | Comparative therapeutic effects of metformin and vitamin E in a model of non-alcoholic steatohepatitis in the young rat. | 2008 | Details |
| A27136 | 20387270 | J Alzheimers Dis | Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease. | 2009 | Details |
| A27137 | 19115316 | Hepatology | VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. | 2009 | Details |
| A27150 | 19077235 | BMC Endocr Disord | The Edinburgh Type 2 Diabetes Study: study protocol. | 2008 | Details |
| A27154 | 19073452 | Orv Hetil | [Silymarin in the treatment of chronic liver diseases: past and future]. | 2008 | Details |
| A27200 | 18997102 | Exp Biol Med (Maywood) | Hyperlipidemic chicken as a model of non-alcoholic steatohepatitis. | 2008 | Details |
| A27221 | 18956293 | Semin Liver Dis | Mechanisms of disease progression in nonalcoholic fatty liver disease. | 2008 | Details |
| A27231 | 18942340 | Pol Merkur Lekarski | [Non invasive markers of non-alcoholic steatohepatitis]. | 2008 | Details |
| A27235 | 18936912 | Naunyn Schmiedebergs Arch Pharmacol | A role for atorvastatin and insulin combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia. | 2008 | Details |
| A27241 | 18922966 | Pharmacol Rev | Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis. | 2008 | Details |
| A27264 | 18806722 | Pediatr Endocrinol Rev | The inflammatory process of adipose tissue. | 2008 | Details |
| A27272 | 18782535 | Zhong Xi Yi Jie He Xue Bao | [Effects of puerarin on expressions of leptin receptor mRNA, phosphorylated Janus kinase 2/phosphorylated signal transducers and activators of transcription 3 proteins in the liver of rats with non-alcoholic fatty liver]. | 2008 | Details |
| A27276 | 18772365 | Am J Physiol Gastrointest Liver Physiol | Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. | 2008 | Details |
| A27280 | 18762907 | Diabetologia | Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? | 2008 | Details |
| A27288 | 18752326 | Hepatology | Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice. | 2008 | Details |
| A27294 | 18713296 | J Gastroenterol Hepatol | Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease. | 2008 | Details |
| A27298 | 18702346 | Pol Merkur Lekarski | [Non-alcoholic fatty liver disease--new view]. | 2008 | Details |
| A27317 | 18654934 | Scand J Gastroenterol | Chitosan ameliorates the severity of steatohepatitis induced by high fat diet in rats. | 2008 | Details |
| A27332 | 18630587 | Zhen Ci Yan Jiu | [Influence of electroacupuncture on insulin-resistance in nonalcoholic fatty liver rats]. | 2008 | Details |
| A27333 | 18627003 | Hepatology | Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. | 2008 | Details |
| A27364 | 18537660 | Curr Pharm Des | Genomics can advance the potential for probiotic cultures to improve liver and overall health. | 2008 | Details |
| A27378 | 18510618 | Am J Gastroenterol | Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. | 2008 | Details |
| A27382 | 18505888 | J Clin Pathol | Clinical and laboratory diagnosis of the metabolic syndrome. | 2008 | Details |
| A27394 | 18484615 | Anat Rec (Hoboken) | Hepatic microcirculation in fatty liver disease. | 2008 | Details |
| A27404 | 18426499 | J Neuroendocrinol | The endocannabinoid system and liver diseases. | 2008 | Details |
| A27408 | 18452708 | Biochem Biophys Res Commun | Free fatty acids sensitize hepatocytes to bile acid-induced apoptosis. | 2008 | Details |
| A27409 | 18452148 | Hepatology | Prevention of free fatty acid-induced hepatic lipotoxicity by 18beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways. | 2008 | Details |
| A27414 | 18433732 | Biochem Pharmacol | Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases. | 2008 | Details |
| A27415 | 18430557 | J Nutr Biochem | The role of fatty acids in the development and progression of nonalcoholic fatty liver disease. | 2008 | Details |
| A27416 | 18422963 | J Gastroenterol Hepatol | Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis. | 2008 | Details |
| A27419 | 18420211 | Atherosclerosis | Do we need to consider inflammatory markers when we treat atherosclerotic disease? | 2008 | Details |
| A27433 | 18395289 | J Hepatol | Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. | 2008 | Details |
| A27435 | 18391799 | Gastroenterol Nurs | Pediatric nonalcoholic fatty liver disease. | 2008 | Details |
| A27466 | 18333122 | HPB (Oxford) | Hepato-pancreato-biliary fat: the good, the bad and the ugly. | 2007 | Details |
| A27472 | 18324772 | J Agric Food Chem | Dietary phosphatidylinositol prevents the development of nonalcoholic fatty liver disease in Zucker (fa/fa) rats. | 2008 | Details |
| A27479 | 18312746 | Clin Invest Med | Basal metabolic rate in morbidly obese patients with non-alcoholic fatty liver disease. | 2008 | Details |
| A27485 | 18302012 | Inflammation | Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis. | 2008 | Details |
| A27497 | 18267346 | J Hepatol | Interleukin-10 is a protective factor against diet-induced insulin resistance in liver. | 2008 | Details |
| A27498 | 18266250 | Hepatology | Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease. | 2008 | Details |
| A27502 | 18251167 | Hepatogastroenterology | Risk factors associated with non-alcoholic fatty liver disease in Chinese patients and the role of tumor necrosis factor-alpha. | 2008 | Details |
| A27503 | 18251157 | Hepatogastroenterology | Plasma levels of interleukin-6 and interleukin-8 in Chinese patients with non-alcoholic fatty liver disease. | 2008 | Details |
| A27504 | 18249301 | Eur J Intern Med | Evolving trends in nonalcoholic fatty liver disease. | 2008 | Details |
| A27509 | 18239590 | Obesity (Silver Spring) | ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats. | 2007 | Details |
| A27521 | 18200676 | World J Gastroenterol | Natural killer T cells and non-alcoholic fatty liver disease: fat chews on the immune system. | 2008 | Details |
| A27522 | 18198478 | J Toxicol Sci | Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. | 2007 | Details |
| A27544 | 18094066 | Am J Physiol Regul Integr Comp Physiol | Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species. | 2007 | Details |
| A27553 | 18081207 | Mol Nutr Food Res | Phenolic compounds: evidence for inhibitory effects against obesity and their underlying molecular signaling mechanisms. | 2008 | Details |
| A27560 | 18066656 | Inflammation | The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet. | 2007 | Details |
| A27573 | 18030620 | Dig Dis Sci | Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis. | 2007 | Details |
| A27578 | 18007556 | Ann Hepatol | Changes in histological criteria lead to different prevalences of nonalcoholic steatohepatitis in severe obesity. | 2008 | Details |
| A27594 | 17958019 | Rev Med Brux | [How to interpret a hyperferritinemia?]. | 2007 | Details |
| A27602 | 17932230 | Am J Physiol Gastrointest Liver Physiol | The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet-induced steatohepatitis. | 2007 | Details |
| A27608 | 17914984 | J Gastroenterol Hepatol | Preventive role of genistein in an experimental non-alcoholic steatohepatitis model. | 2007 | Details |
| A27623 | 17896181 | Eur J Epidemiol | Prevalence of non-alcoholic fatty liver and characteristics in overweight adolescents in the general population. | 2007 | Details |
| A27631 | 17875176 | J Intern Med | Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. | 2007 | Details |
| A27634 | 17868334 | J Gastroenterol Hepatol | Interstrain differences in susceptibility to non-alcoholic steatohepatitis. | 2007 | Details |
| A27635 | 17868330 | J Gastroenterol Hepatol | Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation. | 2007 | Details |
| A27639 | 17845148 | Expert Opin Ther Targets | Present and future therapeutic strategies in non-alcoholic fatty liver disease. | 2007 | Details |
| A27650 | 17761893 | J Endocrinol | Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet. | 2007 | Details |
| A27652 | 17729403 | World J Gastroenterol | Pathogenesis and management issues for non-alcoholic fatty liver disease. | 2007 | Details |
| A27656 | 17722791 | Tunis Med | [Role of mitochondrial dysfunction in non-alcoholic steatohepatitis]. | 2003 | Details |
| A27660 | 17567476 | J Gastroenterol Hepatol | Role of adipocytokines in hepatic fibrogenesis. | 2007 | Details |
| A27663 | 17567458 | J Gastroenterol Hepatol | Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)? | 2007 | Details |
| A27668 | 17708600 | World J Gastroenterol | Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection. | 2007 | Details |
| A27675 | 17694770 | Niger J Med | Diabetes co-existing with chronic liver disease: clinical features and response to therapy. | 2007 | Details |
| A27676 | 17691915 | Curr Drug Discov Technol | Current treatment strategies for non-alcoholic fatty liver disease (NAFLD). | 2007 | Details |
| A27677 | 17690317 | Arterioscler Thromb Vasc Biol | Fatty liver: a novel component of the metabolic syndrome. | 2007 | Details |
| A27683 | 17675901 | J Cardiometab Syndr | Nonalcoholic steatohepatitis and the cardiometabolic syndrome. | 2006 | Details |
| A27701 | 17627552 | Curr Pharm Des | Non-alcoholic fatty liver disease in the metabolic syndrome. | 2007 | Details |
| A27702 | 17619535 | Acta Gastroenterol Belg | Pathogenesis of steatohepatitis: insights from the study of animal models. | 2007 | Details |
| A27703 | 17618414 | Diabetologia | Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice. | 2007 | Details |
| A27732 | 17544977 | Clin Liver Dis | Non-alcoholic steatohepatitis in children. | 2007 | Details |
| A27736 | 17544972 | Clin Liver Dis | Pathogenesis of NASH: animal models. | 2007 | Details |
| A27746 | 17539815 | Hepatol Res | A prospective study of acute drug-induced liver injury in patients suffering from non-alcoholic fatty liver disease. | 2007 | Details |
| A27750 | 17524368 | Biochem Pharmacol | Modulation of hepatic microsomal triglyceride transfer protein (MTP) induced by S-nitroso-N-acetylcysteine in ob/ob mice. | 2007 | Details |
| A27751 | 17520517 | Semin Liver Dis | The role of cytokines and chemokines in the development of steatohepatitis. | 2007 | Details |
| A27755 | 17512085 | J Hepatol | Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. | 2007 | Details |
| A27768 | 17486049 | Mod Pathol | Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach. | 2007 | Details |
| A27770 | 17483247 | J Clin Pathol | A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease. | 2007 | Details |
| A27777 | 17471859 | Rev Gastroenterol Mex | Nonalcoholic fatty liver disease. | 2005 | Details |
| A27786 | 17452309 | Orv Hetil | [Common occurrence of non-alcoholic fatty liver disease and cholecystolithiasis]. | 2007 | Details |
| A27804 | 17397511 | Hepatol Res | Protection of estrogens against the progression of chronic liver disease. | 2007 | Details |
| A27811 | 17387612 | Dig Dis Sci | Musculoskeletal complaints and serum autoantibodies associated with chronic hepatitis C and nonalcoholic fatty liver disease. | 2007 | Details |
| A27813 | 17376042 | J Gastroenterol Hepatol | Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years. | 2007 | Details |
| A27839 | 17296492 | J Nutr Biochem | Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition. | 2007 | Details |